Sign in

NCT06323421Completed

Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer

Mindfulness and CRC Risk Factor Reduction: Targeting Chronic Stress For Colorectal Cancer Risk Factor Reduction A Pilot Feasibility Study Among Vulnerable At-Risk Black Females

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

Many neighborhoods in Chicago experience daily exposure to stressors including economic inopportunity and violent crime in public spaces. There is mounting evidence that chronic psychosocial stress can facilitate carcinogenesis by modulating the gut microbiome and immune system. The proposed research aims to study the practice of mindfulness to mitigate CPS and reduce colorectal cancer risk factors among Black American women at elevated risk.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
1 Mar 2024
Start date
15 Jul 2024
Primary completion date
10 Jul 2025
Lead sponsor
University of Illinois Chicago
NCT number
NCT06323421

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 15 Jul 2024 to the primary completion date, 10 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Bariatric surgery or bowel resection

Other illness

  • History of CRC
  • Inflammatory bowel disease or genetic predisposition to CRC
  • Cancer diagnosis or cancer treatment in the past 12 months
  • Immunodeficiency/autoimmune disease
  • Significant health conditions or take medications that impact participation or expected outcomes (e.g., β-blocker, Cushing's syndrome, and corticosteroids - inhaled, topical, oral in the past month given effects on hair cortisol measurement)

Lab values

  • Uncontrolled diabetes (HbA1c \> 9% based on EHR)

Other

  • Antibiotics (oral/IV) in the past 2 months
  • Consume \> 50 grams of ethanol daily
  • Use combustible tobacco
  • Fiber or pre-/probiotic supplements \> 3 days per week
  • Serrated adenoma at the recent colonoscopy given the molecular features are distinct

Who the study is looking for

  • Female based on sex assigned at birth
  • Self-identify as Black
  • Age 45-65 years old
  • Completed a colonoscopy in the past 24 months,
  • Classify as elevated risk of CRC defined as: any colorectal adenoma detected in past 24 months
  • Own and use a smartphone, computer, or tablet with access to the Internet
  • Score ≥ 14 on the PSS at screening
  • Reside in a Chicago community with high violent crime

Age in the registry: 45 years to 65 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Illinois Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.